Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan

Journal of Oral Pathology and Medicine

Volumn 27, Issue 9, 1998, Pages 428-433

  Kuo, Mark Yen Ping ^a   Cheng, Shih Jung ^a   Chen, Hsin Ming ^a   Kok, Sang Heng ^a   Hahn, Liang Jiunn ^a   Chiang, Chun Pin ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

CD44; Immunohistochemistry; Oral cancer; Survival analysis

Indexed keywords

EID: 0032191198     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1998.tb01980.x     Document Type: Article

References (25)

1. GUNTHERT U CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993; 184: 47-63.
2. LESLEY J, HYMAN R, KINCADE PW. CD44 and its interaction with the extracellular matrix. Adv Immunol 1993; 54: 271-335.
3. Fox SB, GATTER KC, JACKSON DG, et al. CD44 and cancer screening. Lancet 1993; 342: 548-9.
4. GUNTHERT U. HOFMANN M, RUDY W. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
5. REBER S, MATZKU S, GUNTHERT U, PONTA H, HERRLICH P, ZOLLER M. Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer 1990; 46: 919-27.
6. SEITER S, ARCH R, REBER S, et al. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993; 177: 443-55.
7. KAUFMANN M, HEIDER KH, SINN HP, MINCKWITZ G, PONTA H, HERRLICH P. Surface expression of distinct CD44 variant exon epitopes on primary breast cancer strongly correlate with poor survival. Lancet 1995; 345: 615-9.
8. WIELENGA VJM, HEIDER KH, OFFERHAUS GJA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 53: 4754-6.
9. MULDER JWT, KRUYT PM, SEWNATH M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344: 1470-2.
10. KAINZ C, KOHLBERGER P, SLIUTZ G, et al. Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol Oncol 1995; 57: 383-7
11. WASHINGTON K, GOTTFRIED MR, TELEN MJ. Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol 1994; 25: 1043-9.
12. HONG RL, PU YS, HSIEH TS, CHU JS, LEE WJ. Expression of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma. J Urol 1995; 153: 2025-8.
13. FUJITA N, YAEGASHI N, IDE Y, et al Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res 1994; 54: 3922-8.
14. SALMI M, GRON-VIRTA K, SOINTU P, GRENMAN R, KALIMO H. Regulated expression of exon v6 containing isoforms of CD44 in man. Downregulation during malignant transformation of tumor of squamocellular origin. J Cell Biol 1993; 22: 431-42.
15. PIFFKO J, BANKFALVI A, KLAUKE K, et al. Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoform during development and progression of oral squamous cell carcinomas. J Oral Pathol Med 1996; 25: 502-6
16. IARC. Betel-quid and areca-nut chewing. Lyon: International Agency for Research on Cancer, Monographs 1986; 37: 141-202.
17. KO YC, CHIANG TA, CHANG SJ, HSIEH SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 1992; 21: 261-4.
18. KWAN HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel quid chewing: a preliminary report. J Formas Med Assoc 1976; 75: 497-505.
19. HERMANEK P, SOBIN LH, eds. TNM classification of malignant tumours. 4th edn. Heidelberg: Springer-Verlag, 1992; 1-34.
20. Kuo MYP, CHANG HH, HAHN LJ, WANG JT, CHIANG CP. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med 1995; 24: 255-60.
21. HEROLD-MENDE C, SITER S, BORN AI, et al. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 1996; 179: 66-73.
22. LIOTTA LA, STEEG PS, STETLER-STEVENSON WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
23. STAUDER R, EISTERER A, THALER J, GUNTHERT U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 1995; 85: 2885-99.
24. CLARKE MR, LANDRENEAU RJ, RESNICK NM, et al Prognostic significance of CD44 expression in adenocarcinoma of the lung. J Clin Pathol Mol Pathol 1995; 48: M200-4.
25. SPAFFORD MF, KOWPPE J, PAN Z, ARCHER PG, MEYERS AD, FRANKLIN WA. Correlation of tumor marker p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamos cell carcinoma. Arch Otolaryngol Head Neck Surg 1996; 122: 627-32.